Ovid Therapeutics Inc.
OVID· Nasdaq
Released May 7, 2020, before the open
10-Q filed May 7, 2020, 37 days after period end · 0001564590-20-023002
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$20.03M | -$13.80M | -$13.18M | -$34.24M |
| EPS Diluted | -$0.37 | -$0.46 | -$0.54 | -$3.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ovid Therapeutics Inc. · CIK 1636651 · Engraved from SEC EDGAR